DBV Technologies SA (DBVT)
11.43
-0.45
(-3.79%)
USD |
NASDAQ |
Nov 12, 16:00
11.40
-0.03
(-0.26%)
After-Hours: 20:00
DBV Technologies Total Liabilities (Quarterly) : 66.70M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 66.70M |
| June 30, 2026 | 62.80M |
| March 31, 2026 | 58.50M |
| December 31, 2025 | 64.95M |
| September 30, 2025 | 57.64M |
| June 30, 2025 | 57.20M |
| March 31, 2025 | 47.69M |
| December 31, 2024 | 38.27M |
| September 30, 2024 | 39.02M |
| June 30, 2024 | 35.10M |
| March 31, 2024 | 34.24M |
| December 31, 2023 | 42.80M |
| Date | Value |
|---|---|
| September 30, 2023 | 45.79M |
| June 30, 2023 | 53.28M |
| March 31, 2023 | 53.83M |
| December 31, 2022 | 52.06M |
| September 30, 2022 | 36.07M |
| June 30, 2022 | 40.56M |
| March 31, 2022 | 35.52M |
| December 31, 2021 | 47.29M |
| September 30, 2021 | 54.03M |
| June 30, 2021 | 57.56M |
| March 31, 2021 | 52.23M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cellectis SA | 226.30M |
| Akari Therapeutics Plc | 20.03M |
| Bicycle Therapeutics Plc | 61.90M |
| EDAP TMS SA | 74.78M |
| Autolus Therapeutics Plc | 495.66M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 215.40M |
| Shareholders Equity (Quarterly) | 148.60M |
| Debt to Equity Ratio | 0.1494 |
| Current Ratio | 3.241 |
| Net Debt Paydown Yield | -0.21% |